F032 - Granulomatous Disorders of the Adult Skin
Friday, March 1; 3:30 PM - 5:30 PM
Following this course, the attendee should be able to:
- Examine the current information about Granuloma annulare (GA), Necrobiosis lipoidica (NL), Sarcoidosis (SAR) and Drug-induced Granulomatosis (DIG)
- Compare the varied clinical presentations of GA, NL, SAR and DIG
- Analyze the different “evidence base” therapeutic options for GA, NL, SAR and DIG
Granulomatous disorders represent a unique group of diseases, both noninfectious and infectious, that require the utmost clinical pathologic correlation combined with a keen sense of inquiry for underlying systemic disease and immunosuppression.
Dermatologists need to be able to differentiate these entities, evaluate patients for specific underlying systemic disease (i.e. from diabetes to cancer), and treat them with a wide range of immunosuppressant to anti-infectious medications.
By being aware of the skin manifestations of these abnormal physiologic responses dermatologists can improve patient safety, outcome and health care costs.
- English, Joseph C. III, MD: no financial relationships exist with commercial interests.
- Rosenbach, Misha, MD: aTyr Pharma – C(H); Derm101 – Independent Contractor(H); JAMA – E(S); Merck & Co., Inc – C(H); Promet Therapeutics, LLC – I(Grants/Research Funding);